Implant Sciences Corp. IMSC
We caught IMSC earlier this week on Tuesday, as it popped up on a routine news scan that morning; the company had announced a potentially lucrative contract with the TSA and the stock was gapping up pretty big.
It took a couple of sessions for the stock to come down and find support, and yesterday following an update on the TSA contract in which we learned that the initial order for over 1100 explosive detectors to be deployed in airports across the country was received, the stock began to run. >> Read PR
From an early low of 1.26 IMSC made a nice 22% intraday move, topping out at 1.54. We want to continue to pay attention to this play as the week comes to a close, in the wake of this morning’s Q1 2015 earnings release, which contains some favorable figures:
- Implant Sciences Reports First Quarter Fiscal 2015 Financial Results (Fri 7:00AM EST)
Off of Today’s News Scan
We’ll group our Extended Watchlist items together with links to the important PR’s each of the companies has out this morning.
Armco Metals Holdings, Inc. AMCO released earnings which beat expectations: ARMCO METALS HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report (Fri 8:32AM EST)
Geron Corp. GERN licensed its cancer treatment to a unit of Johnson & Johnson for up to $935 million: Geron could get $935M in blood disorder drug deal (Thu, Nov 13)
SkyPeople Fruit Juice, Inc. SPU announced vastly increased Q3 revs:SkyPeople Q3 Revenue Up 79% to $34.8 Million, Net Income Increases 45% to $4.7 Million (Fri 6:00AM EST)
Blonder Tongue Laboratories, Inc. BDR also released earnings today: BLONDER TONGUE LABORATORIES INC Files SEC form 10-Q, Quarterly Report (Fri 8:31AM EST)
Immunocellular Therapeutics, Inc. IMUC announced continued favorable results from trials of their dendritic cell-based immunotherapeutic vaccine: ImmunoCellular Therapeutics Presents Updated ICT-107 Phase II Data at the Society for Neuro-Oncology Annual Meeting 2014 (Fri 6:00AM EST)